Detalhe da pesquisa
1.
Clinical Pattern of Tolvaptan-Associated Liver Injury in Trial Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD): An Analysis of Pivotal Clinical Trials.
Am J Kidney Dis
; 81(3): 281-293.e1, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36191725
2.
Safety and efficacy of Tolvaptan in real-world patients with autosomal dominant polycystic kidney disease- interim results of SLOW-PKD surveillance.
Clin Exp Nephrol
; 25(11): 1231-1239, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34228250
3.
Overweight and Obesity and Progression of ADPKD.
Clin J Am Soc Nephrol
; 16(6): 908-915, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34117082
4.
Preclinical studies of vorinostat (suberoylanilide hydroxamic acid) combined with cytosine arabinoside and etoposide for treatment of acute leukemias.
Clin Cancer Res
; 15(5): 1698-707, 2009 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19223502